GALMED PHARMACEUTICALS LTD. Current Liabilities
GALMED PHARMACEUTICALS LTD. (GLMD) had Current Liabilities of $2.81 million as of 2026-06-30, per its 6-K filed 2026-09-02.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-09-02
- 2026-06-30: Liabilities, Current $2.81M.
- 2025-12-31: Liabilities, Current $2.85M.
- 2025-09-30: Liabilities, Current $2.47M.
- 2025-06-30: Liabilities, Current $2.42M.
| Period end | Liabilities, Current |
|---|---|
| 2026-06-30 | $2.81M 6-K · filed 2026-09-02 |
| 2025-12-31 | $2.85M 6-K · filed 2026-09-02 |
| 2025-09-30 | $2.47M 6-K · filed 2025-11-26 |
| 2025-06-30 | $2.42M 6-K · filed 2025-08-28 |
| 2024-12-31 | $2.17M 20-F · filed 2026-03-31 |
| 2024-06-30 | $1.55M 6-K · filed 2024-08-28 |
| 2023-12-31 | $2.75M 20-F · filed 2025-04-02 |
| 2023-06-30 | $2.72M 6-K · filed 2023-08-09 |
| 2022-12-31 | $3.09M 20-F · filed 2024-04-04 |
| 2022-06-30 | $2.73M 6-K · filed 2022-08-04 |
| 2021-12-31 | $5.88M 20-F · filed 2023-03-29 |
| 2021-06-30 | $7.01M 6-K · filed 2021-08-05 |
| 2020-12-31 | $8.01M 20-F · filed 2022-05-02 |
| 2020-06-30 | $4.71M 6-K · filed 2020-08-06 |
| 2019-12-31 | $6.93M 20-F · filed 2021-03-18 |
| 2019-06-30 | $3.28M 6-K · filed 2019-08-05 |
| 2018-12-31 | $2.71M 20-F · filed 2020-03-12 |
| 2018-06-30 | $3.80M 6-K · filed 2018-08-02 |
| 2017-12-31 | $3.85M 20-F · filed 2019-03-13 |
| 2017-06-30 | $3.63M 6-K · filed 2017-07-31 |
| 2016-12-31 | $4.58M 20-F · filed 2018-03-13 |
| 2016-06-30 | $3.35M 6-K · filed 2017-06-23 |
| 2015-12-31 | $2.54M 6-K · filed 2017-06-23 |
| 2014-12-31 | $1.12M 20-F · filed 2016-03-22 |
| 2013-12-31 | $1.69M 20-F · filed 2015-03-31 |